Study of ZG0895.HCl in Patients With Advanced Solid Tumors

NCT05877664 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: ZG0895 Hydrochloride for Injection

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd